High-dose 13.3mg/24h rivastigmine transdermal patch demonstrates efficacy on instrumental activities of daily living: analysis of autonomy and higher-level function subscales

نویسندگان

  • G. Alva
  • M. Filippi
چکیده

cancelled P2035 Epigenetic mechanisms in a rare case of monozygotic twins discordant for Alzheimer’s disease C. D’Addario1, B. Arosio2, A. Di Francesco1, C. Abbate2, A. Casè3, L. Bergamaschini3,4, D. Mari2, M. Maccarrone1,5 1Biomedical Sciences, University of Teramo, Teramo, 2Geriatric Unit, Department of Clinical Sciences and Community, 3A.S.P. Pio Albergo Trivulzio, 4Medical Sciences, University of Milan, Milan, 5European Center for Brain Research (CERC)/Santa Lucia Foundation, Rome, Italy Case report: Target genes in Alzheimer’s disease (AD) have been identified. The study of rare monozygotic (MZ) twins discordant for AD provides a unique opportunity to evaluate the role of environmental factors in the etiology of the disease. Since epigenetic differences could contribute to phenotypic differences, we investigated either global changes in selected chromatin modifications as well as DNA methylation in peripheral blood mononuclear cells of a couple of these MZ twins. Moreover, we analysed the gene expression of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) directly recruited by DNMTs. We observed, in the AD twin, markers of transcriptional activation namely a strong reduction in DNA methylation, revealed by higher levels of [3H]methyl group incorporated into DNA (AD twin=2.86±0.23 fold over healthy twin =1±0.16), as well as a clear reduction in histone 3 acetylation at lysine 9 (AD twin=34% versus healthy twin=100%). Consistently, we observed increases in the gene expression of few HDACs isoforms in the AD twin (HDAC2 (3,39), HDAC6 (2,08) HDAC9 (4,16) versus healthy twin =1) and no changes in all the others. Finally, slightly changes were observed in the other histone modifications investigated (Histone 3 Lysine 4 trimethylation, Histone 3 Lysine27 trimethylation) and in all the DNMTs isoforms mRNA levels. Our results unravel epigenetic differences potentially helpful in the understanding of environmental factors and phenotypic differences in MZ twins. We also confirm the use of peripheral blood cells as useful model for the study of gene regulation that mirrors the alterations within the brain.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses.

OBJECTIVE In Alzheimer's disease (AD), rivastigmine has demonstrated statistically significant efficacy versus placebo on cognition and activities of daily living (ADL). The aim of this retrospective analysis was to further evaluate the treatment effects of rivastigmine on individual ADL items. METHODS This exploratory analysis focused on the Alzheimer's Disease Cooperative Study Activities o...

متن کامل

Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles

Here we report a novel approach for preparation of a 6-day transdermal drug delivery system (TDDS) as treatment for mild to moderate Alzheimer’s disease. The spray drying method was used to prepare microparticles containing the anti-Alzheimer drug. The content of the drug was determined by High Performance Liquid Chromatography (HPLC) method. The morphology and size range of the microparticles ...

متن کامل

Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles

Here we report a novel approach for preparation of a 6-day transdermal drug delivery system (TDDS) as treatment for mild to moderate Alzheimer’s disease. The spray drying method was used to prepare microparticles containing the anti-Alzheimer drug. The content of the drug was determined by High Performance Liquid Chromatography (HPLC) method. The morphology and size range of the microparticles ...

متن کامل

Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease.

AIM Determine whether patients with Alzheimer's disease demonstrating functional and cognitive decline, following 24-48 weeks of open-label treatment with 9.5 mg/24 h (10 cm(2)) rivastigmine patch, benefit from a dose increase in a double-blind (DB) comparative trial of two patch doses. METHODS Patients meeting prespecified decline criteria were randomized to receive 9.5 or 13.3 mg/24 h (15 c...

متن کامل

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

OBJECTIVE Investigate efficacy of 13.3 mg/24 h rivastigmine patch in patients with severe Alzheimer's disease on Alzheimer's Disease Cooperative Study-Activities of Daily Living Scale-Severe Impairment Version items and domains. METHODS Retrospective analysis of the 24-week, randomized, double-blind ACTivities of daily living and cognitION (ACTION) study, using factor analysis to establish "b...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012